United States· US:68788-8714_06743d22-d4e5-4543-9b01-e33febeba791
Megestrol Acetate
A megestrol product containing megestrol acetate, registered in United States by Preferred Pharmaceuticals Inc.. The same ATC class is registered in 11 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Megestrol is registered in 11 of 19 countries.
Countries holding a registration under ATC L02AB01 (megestrol), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Megestrol · ATC L02AB01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Statesprice
Price per daily dose
What a daily dose of megestrol costs, country by country.
Normalised to the WHO defined daily dose (0.16 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Megestrol · price per daily dose (0.16 g)
USD · FX 28 Sept 2026
- IT Italy$2.30
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- Megestrol Acetate
- Manufacturer
- Preferred Pharmaceuticals Inc.
- Country
- United States (US)
- ATC code
- L02AB01
- ATC class
- Megestrol
- Defined daily dose
- 0.16 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc116878887142240 mL in 1 BOTTLE, PLASTIC (68788-8714-2)
Regulatory notes
Interactions
152 interactions on record for megestrol.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Megestrol · interactions on record
152 records
- 2 severe
- 147 moderate
- 3 minor
Most severe, free to view
- DofetilideC01BD04severe
- ThalidomideL04AX02severe
- AprepitantA04AD12moderate
- LiraglutidA08AX02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Megestrol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- IrelandMegace 40 mg/ml oral suspensionOriginalis B.V.
- PolandCachexanPolfarmex S.A.
- SpainMAYGACE ALTAS DOSIS 40 mg/ml SUSPENSION ORALBausch Health Ireland Limited
- CzechiaMEGACEBausch Health Ireland Limited, Dublin
- United KingdomMegace 160mg tabletsDowelhurst Ltd
- ItalyGESTROLTEXISTITUTO GENTILI S.R.L.
- FinlandMegaceBristol-Myers Squibb Ab
- CanadaMEGESTROLAA PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Belgium · Megace
- Cyprus · Megace
- Czechia · Megace, Megaplex
- Germany · Megestat
- Spain · Borea, Maygace Altas Dosis
- France · Megace
- United Kingdom (Northern Ireland) · Megace
- Greece · Megace
- Croatia · Megace, Megostat
- Hungary · Cachexi, Megace
- Ireland · Megace
- Italy · Gestroltex, Megace
- Lithuania · Megace
- Luxembourg · Megace
- Netherlands · Megestrolacetaat Focus
- Norway · Megace
- Poland · Cachexan, Megace
- Portugal · Megace, Megestrol Generis
- Romania · Megesin
- Sweden · Megace
- Slovenia · Megace
- Slovakia · Megesin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/aa86c27d-cd5d-4000-8a86-6354fc21af20 GET /v1/drugs/aa86c27d-cd5d-4000-8a86-6354fc21af20?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "TJ2M0FR8ES",
"rxcui": "29451",
"inchikey": "RQZAXGRLVPAYTJ-GQFGMJRRSA-N",
"display_name": "MEGESTROL ACETATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "ORAL",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 1
},
"spl_meta": {
"2dc921d5-e423-4379-a345-151e87d13651": {
"match": "brand_token",
"title": "MEGESTROL ACETATE SUSPENSION [UPSHER-SMITH LABORATORIES, LLC]",
"spl_version": "19",
"published_date": "2026-05-01"
}
},
"productid": "68788-8714_06743d22-d4e5-4543-9b01-e33febeba791",
"productndc": "68788-8714",
"dosage_form": "SUSPENSION",
"orange_book": {
"appl_no": "075671",
"products": [
{
"rs": true,
"rld": false,
"te_code": "AB",
"strength": "40MG/ML",
"product_no": "001",
"approval_date": "Jul 25, 2001"
}
],
"appl_type": "A"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "MEGESTROL ACETATE",
"proprietary_name": "Megestrol Acetate",
"active_ingred_unit": "mg/mL",
"application_number": "ANDA075671",
"marketing_category": "ANDA",
"nonproprietary_name": "Megestrol Acetate",
"start_marketing_date": "20240712",
"active_numerator_strength": "40"
}See everything about megestrol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.